Si-Bone (SIBN) Cash from Investing Activities (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147.84% |
| Dec 31, 2025 | 229.94% |
| Sep 30, 2025 | -5.85% |
| Jun 30, 2025 | -189.10% |
| Mar 31, 2025 | 145.10% |
| Dec 31, 2024 | 15.07% |
| Sep 30, 2024 | 305.96% |
| Jun 30, 2024 | -128.83% |
| Mar 31, 2024 | 133.56% |
| Dec 31, 2023 | 65.53% |
| Sep 30, 2023 | -2,505.52% |
| Jun 30, 2023 | -80.51% |
| Mar 31, 2023 | 13,049.44% |
| Dec 31, 2022 | -98.98% |
| Sep 30, 2022 | -20.50% |
| Jun 30, 2022 | 148.55% |
| Mar 31, 2022 | -247.02% |
| Dec 31, 2021 | -42.52% |
| Sep 30, 2021 | 61.44% |
| Jun 30, 2021 | 332.67% |
| Mar 31, 2021 | 89.50% |
| Dec 31, 2020 | -1,215.09% |
| Sep 30, 2020 | -176.73% |
| Jun 30, 2020 | 101.29% |
| Mar 31, 2020 | -40.11% |
| Dec 31, 2019 | -27.83% |
| Sep 30, 2019 | 34.49% |
| Jun 30, 2019 | 203.44% |
| Mar 31, 2019 | 94.28% |
| Dec 31, 2018 | -156,429.03% |
| Sep 30, 2018 | 87.53% |
| Jun 30, 2018 | -127.98% |
| Mar 31, 2018 | -101.85% |